Qilian International Holding Group Ltd - Class A
Research Qilian International Holding Group Ltd - Class A (BGM) on Bullrun: market cap USD 2.16B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBGM
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 2.16B
- Financial periodQ1 2026
Valuation Snapshot
latest market cap is USD 2.16B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 37.92M | -USD 19.94M | -USD 4.56M | 16.6% | -0.18 | USD 9.82M | USD 1.94M | USD 390.88M |
| FY2024 | USD 25.10M | -USD 1.44M | USD 304.11K | 16.4% | -0.2 | USD 9.82M | USD 0 | USD 42.74M |
| FY2023 | USD 46.47M | -USD 7.78M | USD 132.45K | 3.8% | -1.08 | USD 7.48M | USD 577.85K | USD 42.79M |
| FY2022 | USD 64.86M | USD 1.08M | USD 10.62M | 9.6% | 0.15 | USD 14.32M | USD 1.77M | USD 53.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 2.16B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 740.30M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 230.06M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 27.60M | n/a | 6.5% | 0.25 |
| 2022 | 2022-12-30 | USD 26.38M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 94.74M | n/a | n/a | n/a |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2023 | 0.25 USD |
About Qilian International Holding Group Ltd - Class A
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Qilian International Holding Group Ltd - Class A's market cap?
Qilian International Holding Group Ltd - Class A's market capitalization is USD 2.16B.
What does Qilian International Holding Group Ltd - Class A do?
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient.